Trial
NCT04853355
Non-Responsive Diabetic Macular Edema and Spironolactone
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Diabetic Maculopathy
Intervention
Spironolactone 50 mg
Why stopped
lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-02